Search

Promising UV-curable starch-based coatings were fabricated by utilizing methacrylated starch. The aqueous methacrylated starch solution was cast on a glass substrate, and UV-cured after drying. The efficiency of UV-curing process was monitored with gel percentage measurements. The thermal and mechanical properties of the fabricated UV-cured coatings were investigated through differential scanning calorimetry and tensile test and compared with the starch-based uncured casted coatings. A complete characterization of the surface properties was performed by means of pencil hardness, adhesion, solvent resistance, and surface tension measurements. The cross-linking by UV-curing significantly enhanced the mechanical and surface properties of the coating. The effect of UV-curing on the biodegradability of the coating was evaluated by following the enzymatic degradation by &alpha, amylase by determining the amount of glucose and maltose released from the coatings. UV-cured methacrylated starch based coating with promising material and surface properties and retained biodegradation potential was demonstrated.

Biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles, containing human parathyroid hormone (PTH (1–34)), prepared by a modified double emulsion-solvent diffusion-evaporation method, were incorporated in porous freeze-dried chitosan-gelatin (CH-G) scaffolds. The PTH-loaded nanoparticles (NPTH) were characterised in terms of morphology, size, protein loading, release kinetics and in vitro assessment of biological activity of released PTH and cytocompatibility studies against clonal human osteoblast (hFOB) cells. Structural integrity of incorporated and released PTH from nanoparticles was found to be intact by using Tris-tricine SDS-PAGE. In vitro PTH release kinetics from PLGA nanoparticles were characterised by a burst release followed by a slow release phase for 3–4 weeks. The released PTH was biologically active as evidenced by the stimulated release of cyclic AMP from hFOB cells as well as increased mineralisation studies. Both in vitro and cell studies demonstrated that the PTH bioactivity was maintained during the fabrication of PLGA nanoparticles and upon release. Finally, a content of 33.3% w/w NPTHs was incorporated in CH-G scaffolds, showing an intermittent release during the first 10 days and, followed by a controlled release over 28 days of observation time. The increased expression of Alkaline Phosphatase levels on hFOB cells further confirmed the activity of intermittently released PTH from scaffolds.